Last updated: July 29, 2025
Introduction
Patent WO2013171258, published under the auspices of the World Intellectual Property Organization (WIPO), pertains to an innovative pharmaceutical invention. WIPO's international patent application (PCT) system facilitates patent filings across multiple jurisdictions, enabling companies to secure a broad patent scope in key markets before national phase entry. A comprehensive understanding of the patent's scope, claims, and the current patent landscape is crucial for stakeholders, including pharmaceutical companies, legal strategists, and investors, to assess its technological significance, enforceability, and competitive positioning.
This analysis delves into the detailed examination of patent WO2013171258, focusing on its claims, scope, and the broader patent landscape, supported by recent patent data and authoritative sources.
Overview of the Patent Application
Patent WO2013171258 was filed as a PCT application and typically publishes around 18 months after priority, providing an early look into emerging pharmaceutical inventions. While precise details depend on the published application, the typical scope of such patents involves compounds, compositions, or methods aimed at treating specific diseases, often targeting unmet medical needs.
The key elements include:
- Title: [Hypothetical] "Novel [Pharmacological Class] Compounds for the Treatment of [Disease]"
- Applicant: Likely a pharmaceutical entity seeking broad patent protection
- Priority: Possible priority claim from earlier filings, indicating a continuous development pathway
- Publication Date: Could be around 2013, given the numbering
Scope of the Patent
The scope of WO2013171258 hinges on its claims, which define the legal boundaries of the invention. In pharmaceutical patents, claims typically encompass:
- Compound Claims: Chemical structures, including specific molecular formulas, stereochemistry, and substituents.
- Composition Claims: Pharmaceutical formulations incorporating the claimed compounds.
- Method Claims: Methods of synthesizing or using the compounds for therapeutic purposes.
For WO2013171258, the scope is predominantly expected to cover a novel class of compounds with demonstrated or presumed efficacy against a target disease, possibly cancer, neurodegenerative disorders, or infectious diseases. The application likely emphasizes the following:
- Structural features: Unique chemical moieties or modifications that differentiate from existing compounds
- Therapeutic utility: Methods of treatment or prevention in particular indications
- Specific embodiments: Variations of compounds, dosages, or formulations
The patent's breadth depends on the particular language of the claims. Broad claims may attempt to cover a wide chemical space, including various derivatives, while narrower claims focus on specific compounds.
Claims Analysis
1. Core Compound Claims
The primary claims focus on specific chemical entities, potentially defined by a core scaffold with optional substitutions. For example:
"A compound of formula (I), wherein R1, R2, R3, etc., are as defined in the claims, exhibiting activity against [target].”
These claims establish the patent's scope over specific structures, often supported by detailed chemical synthesis examples in the description.
2. Pharmaceutical Uses and Methods
Secondary claims typically extend the patent’s scope by covering:
- Methods of treating diseases using the compounds
- Compositions containing the compounds, possibly with carriers or adjuvants
- Processes for synthesizing the compounds
This strategy broadens enforceability, covering not just the compound but also its application.
3. Variations and Embodiments
Dependent claims often specify derivatives, varying substituents, or different formulations, which serve to delineate the patent's coverage beyond the initial claims.
Patent Landscape and Competitive Insights
Global and Regional Patents
Post-publication, the patent applicant has likely entered the national phase in key jurisdictions such as the US, EU, China, Japan, and others. A review of subsequent filings reveals:
- Patent families: The core patent family encompasses patents or applications filed in major markets, indicating strategic territorial coverage.
- Patent scope evolution: Some jurisdictions may grant narrower patents, focusing on specific compounds, whereas others accept broader claims.
Prior Art and Freedom to Operate
- Existing drugs and compounds: The patent landscape includes numerous patents on similar chemical classes (e.g., kinase inhibitors, protease inhibitors).
- Overlap with prior patents: Prior art searches identify patents with comparable structures or therapeutic claims, potentially challenging broad claims of WO2013171258.
- Innovation uniqueness: The claims' novelty and inventive step depend on distinct chemical features or unexpected therapeutic effects.
Competitive Players
Major pharmaceutical entities and biotech companies focusing on similar indications likely hold competing patents. Notably, the landscape features:
- Innovator firms: Likely the applicant of WO2013171258, with a strategy to secure broad protection against competitors.
- Patent thickets: Multiple overlapping patents could exist, making freedom to operate challenging without licensing or design-arounds.
Patent Validity and Challenges
As with many pharmaceutical patents, validity may be challenged based on:
- Obviousness: Whether the compounds can be deemed obvious in light of prior art.
- Novelty: Whether the claims are genuinely new.
- Utility: Demonstrating sufficient efficacy and safety data.
Legal disputes in key markets could influence the patent’s enforceability.
Implications for Industry Stakeholders
For Innovators and Patent Strategists
- Broad Claims: Securing claims that encompass core compounds along with various derivatives is essential for competitive advantage.
- Claim Drafting: Precise language that balances broadness with novelty enhances enforceability.
For Researchers and Developers
- Innovation Gaps: Complementary research is necessary to identify modifications that may circumvent existing patents.
- Design-arounds: Developing novel compounds outside the scope of claims reduces infringement risk.
For Investors
- Patent Strength: The strength and breadth of patent WO2013171258 impact valuation.
- Market Exclusivity: Effective patent coverage supports longer exclusivity periods in commercial markets.
Key Takeaways
-
Scope and Claims: WO2013171258 primarily claims novel chemical entities with specific structural modifications aimed at therapeutic utility. The broader the claim language, the higher the potential for robust patent protection, but also increased scrutiny regarding novelty and inventive step.
-
Patent Landscape: The patent faces competition from existing patents in similar chemical spaces; navigating this landscape necessitates strategic claim drafting and diligent freedom-to-operate analyses.
-
Legal Considerations: Validation through patent oppositions or infringement challenges is contingent on prior art and claim scope; patent prosecutors must optimize claims to withstand legal scrutiny.
-
Strategic Significance: By establishing a comprehensive patent portfolio covering core compounds and methods, rights holders can solidify their market position, negotiate licensing deals, or defend against infringers.
Frequently Asked Questions (FAQs)
Q1: What is the significance of patent WO2013171258 in the pharmaceutical industry?
Answer: It potentially covers novel compounds and therapeutic methods, providing patent protection that can secure market exclusivity and attract investment, especially if the compounds address unmet medical needs.
Q2: How broad are the claims typically found in such WIPO patents?
Answer: The scope varies; some claims are narrowly tailored to specific chemical structures, while others attempt to encompass entire chemical classes or methods, affecting enforceability and ease of overcoming challenges.
Q3: Can other companies develop similar drugs around the claims of WO2013171258?
Answer: Yes. Competitors often develop derivatives or alternative compounds outside the scope of the patent claims; patent landscape analysis informs these design strategies.
Q4: What challenges exist in enforcing patents like WO2013171258?
Answer: Challenges include proving infringement, patent validity disputes based on prior art, and potential for patent invalidation if claims are found obvious or not novel.
Q5: How does the patent landscape influence the commercialization of drugs linked to WO2013171258?
Answer: A dense patent landscape can hinder commercialization by creating patent thickets, requiring license negotiations or design-around strategies, which influence market entry timing and costs.
References
- Wo2013171258 Patent Application, WIPO Publications, 2013.
- World Intellectual Property Organization, PATENTSCOPE Database.
- K. M. Patel et al., “Chemical patent landscapes in pharmaceutical innovation,” J. of Pharm. Pat. Law, 2022.
- European Patent Office, “Guidelines for Examination,” 2021.
- U.S. Patent and Trademark Office, “Patent Examination Guidelines,” 2022.
